The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

Table 3 Baseline characteristics of IPD cases linked to patient records

Description	IPD Cases linked to patient records	Completed Follow-up (%)	Vaccination status known (%)	With >1 Risk factor (%) *
Number of subjects	396	368	348	61
Male (%)	198 (50.0)	181 (49.2)	171 (49.1)	28 (45.9)
Aged 65 + years (%)	165 (41.7)	156 (42.4)	145 (41.7)	43 (70.5)
% VHR^§	-	29 (7.9)	23 (6.6)	-

* With >1 risk factor: more than one known risk factor for pneumococcal disease as set out in non-age dependent criteria to be eligible for polysaccharide vaccine [12].
^§ VHR denotes IPD cases in the very high risk category – defined as asplenics and the severely immuno-compromised (haematological malignancies and non-haematological malignancies who are currently receiving cancer therapy).

ISSN: 1471-2334